TIAGABINE: ADD-ON TREATMENT FOR PARTIAL SEIZURES

摘要

Up to 30% of patients with epilepsy have seizures resistant to available treatments. We consider here the place of tiagabine (Gabitril - Sanofi-Synthelabo), which was recently introduced as an "add-on therapy for partial seizures with or without secondary generalisation where control is not achieved by optimal doses of at least one other anti-epileptic".